BCM
HIMS icon

Bayesian Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bayesian Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,908
Closed -$434K – 262
2026
Q1 		$434K Buy
+20,908
New +$494K 0.53% 63
2025
Q1 		– Sell
-37,579
Closed -$909K – 759
2024
Q4 		$909K Buy
+37,579
New +$931K 0.11% 245
2024
Q3 		– Sell
-93,600
Closed -$1.89M – 829
2024
Q2 		$1.89M Sell
93,600
-20,800
-18% -$346K 0.22% 122
2024
Q1 		$1.77M Buy
+114,400
New +$1.29M 0.17% 172
2023
Q4 		– Sell
-52,883
Closed -$333K – 868
2023
Q3 		$333K Buy
52,883
+13,300
+34% +$98.9K 0.04% 450
2023
Q2 		$372K Sell
39,583
-44,800
-53% -$444K 0.04% 482
2023
Q1 		$837K Buy
84,383
+49,053
+139% +$430K 0.1% 269
2022
Q4 		$226K Buy
35,330
+5,200
+17% +$29.6K 0.03% 563
2022
Q3 		$168K Sell
30,130
-27,000
-47% -$163K 0.03% 542
2022
Q2 		$259K Buy
57,130
+36,000
+170% +$154K 0.05% 529
2022
Q1 		$113K Sell
21,130
-19,900
-49% -$98.4K 0.02% 691
2021
Q4 		$269K Buy
+41,030
New +$297K 0.09% 269

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bayesian Capital Management's HIMS Position: Q2 2026 in Review

Bayesian Capital Management sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 20,908 shares — an estimated $434K sold.

Bayesian Capital Management first reported a position in HIMS in Q4 2021 and held it in 12 quarters. The position peaked at $1.89M in Q2 2024. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Bayesian Capital Management reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 20,908 Hims & Hers Health shares in Q2 2026, an estimated $434K.
  • Bayesian Capital Management first reported a position in Hims & Hers Health in Q4 2021 and held it in 12 quarters.
  • Bayesian Capital Management's Hims & Hers Health position peaked at $1.89M in Q2 2024.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.